Science on Trial – The Debates
This year, we are proud to introduce the first ‘Science on Trial’, a unique opportunity to participate in a real medical debate, express your opinion, listen to opposing ideas and develop your critical thinking skills!
We will be holding two different debates on the following subjects:
- Should we use gene editing to produce disease-free babies?
- Is enforcing a 50-50 ratio of Male to Female students in Medical Schools ethically acceptable?
You can participate either as:
– an active member of the debate teams, or
– an audience member
The members of the debate teams will be selected beforehand and once the debate teams are announced and assigned a topic, the members will be required to prepare for the debate prior to the congress. Each debate team will consist of 5 members and there will be two teams for each topic.
The deadline to apply as a member of the debate teams is February 28th. The participants who have applied, will be contacted and asked to write a short motivation letter regarding the two topics.
The teams will be announced on March 10th and the members will be required to start preparations then.
“A debate is essentially a discussion in which opposing arguments are presented. It is said to be one of the best tools in problem solving, as it engages people and forces them to take ownership of their opinions in the process of forming their arguments. In the medical world specifically, debating is a part of a doctor’s everyday life. By moving away from a patriarchal system, the job of a doctor now includes convincing patients as well as colleagues of the validity of his/hers reasoning. Therefore it is becoming essential to be able to present in a clear and concise manner why the course of treatment you have chosen is the best option available.
On a larger scale, a debate is the only way in which health policy is created or changed, by independent governments and international organizations alike. An example is the introduction of new guidelines for HIV-self testing by WHO, which had the aim of improving access to HIV diagnosis, followed by a debate on the issue,in November of last year.”